Thomanai Lamtha a medical technologist, earned his Ph.D. in Biochemistry from Kasetsart University, Bangkok, Thailand, in 2022. He was a postdoctoral researcher in the Spectroscopic and Sensing Devices Research Group at the National Electronics and Computer Technology Center (NECTEC) in Thailand and a visiting researcher at Utrecht Science Park in the Netherlands (Faculty of Science, Utrecht University). Currently a lecturer in the Department of Clinical Chemistry, Faculty of Medical Technology, Nation University. His research focuses on antibody engineering for targeted cancer therapy and the discovery of natural-based compounds targeting cancer and pathogen infections.